基本信息
-
瑞他帕林; 瑞他莫林
-
224452-66-8
-
瑞他帕林
-
C30H47NO4S
-
517.76
-
Acetic acid,2-[[(3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]thio]-,(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-ylester
-
639-491-7
-
1.16±0.1 g/cm3(Predicted)
-
Aceticacid, [[(3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]thio]-,(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-ylester (9CI); Altabax; Altargo; Mutilin14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)acetate; Retapamulin; SB275833
-
331ºC
-
-
623.8ºC at 760mmHg
-
详细信息
CAS号:224452-66-8
1. 适应症:用于局部治疗金黄色葡萄球菌或化脓链球菌感染的脓胞病
2. 类别:3+3类
3. 原料+软膏剂
4. 规格:5mg
5. 研发进度:现已完成全部资料的整理、待报生产;中试合成工艺优化完成